Duyuru • Aug 02
A consortium of existing stockholders, holding over 90% of the voting shares and led by Knighthead Capital Management, LLC and Marathon Asset Management Limited acquired an unknown minority stake in ATI Physical Therapy, Inc. (OTCPK:ATIP). A consortium of existing stockholders, holding over 90% of the voting shares and led by Knighthead Capital Management, LLC and Marathon Asset Management Limited acquired an unknown minority stake in ATI Physical Therapy, Inc. (OTCPK:ATIP) on August 1, 2025. The merger will take the company private. As a result of the merger, shares not held by this group of stockholders will be acquired for $2.85 per share in cash.
A consortium of existing stockholders, holding over 90% of the voting shares and led by Knighthead Capital Management, LLC and Marathon Asset Management Limited completed the acquisition of an unknown minority stake in ATI Physical Therapy, Inc. (OTCPK:ATIP) on August 1, 2025. Duyuru • Apr 03
ATI Physical Therapy Advances Connected Musculoskeletal Care with Integrated Digital Solutions ATI Physical Therapy is transforming patient access to high-quality care with an enhanced digital and virtual care experience. By integrating in-person treatment with advanced digital tools and virtual musculoskeletal (MSK) care, ATI is creating a more connected and flexible patient journey. Technological enhancements remove barriers to care and improve patient outcomes through: A reimagined digital experience that delivers easier access, personalized treatment plans, real-time progress tracking, and interactive rehabilitation tools. A virtual care pathway with on-demand assessments, guided triage, and early intervention, ensuring streamlined access to high-quality MSK care. Remote therapeutic monitoring (RTM) to improve adherence and keep patients engaged in their recovery. Reduced healthcare costs by enabling early intervention and preventative care, removing barriers to access, and optimizing care delivery through hybrid care pathways. Proven Impact of Hybrid Care: This innovation builds on ATI's long-standing Single Platform approach, anchored on: Convenient access with in-clinic and virtual care options for trusted care; Scaled clinical pathways delivering exceptional patient experience and outcomes; Comprehensive clinical training backed by real world research in partnership with Institute for Musculoskeletal Advancement. With a focus on delivering high-quality care, ATI Physical Therapy is dedicated to improving patients' quality of life through personalized treatment plans aimed to meet each patient's goals. ATI offers a wide range of services, including sports physical therapy, women's health, hand therapy, worker's compensation rehabilitation, and other specialty programs tailored to meet the unique needs of each patient. In some cases, patients can begin treatment right away without needing a prescription or medical referral, making care more accessible and convenient. With flexible hours and easy online booking, ATI ensures high-quality MSK care is always within reach. Duyuru • Mar 18
ATI Physical Therapy, Inc. Files Form 15 ATI Physical Therapy, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Class A common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Class A common stock was $0.0001 per share. Duyuru • Dec 26
ATI Physical Therapy, Inc. Announces Resignation of Joseph Jordan as Chief Financial Officer, Effective January 10, 2025 ATI Physical Therapy, Inc. announced that Joseph Jordan provided notice to the Company that he will resign from his position as Chief Financial Officer of the Company effective as of the end of business on January 10, 2025 . Mr. Jordan is resigning to pursue other opportunities. Mr. Jordan’s resignation is not the result of a disagreement with the Company or the Company’s Board of Directors or of any matter relating to the Company’s operations, financial statements, policies or practices. The Company thanks Mr. Jordan for his dedicated services and wishes him well in his future endeavors. The Company has begun a search for Mr. Jordan’s successor. Duyuru • Dec 17
ATI Physical Therapy, Inc. (OTCPK:ATIP) announces an Equity Buyback for 1,650,000 shares, for $4.7 million. ATI Physical Therapy, Inc. (OTCPK:ATIP) announces a share repurchase program. Under the program, the company will repurchase up to 1,650,000 shares for $4.7 million. The shares will be repurchased at a price of $2.85 per share. If the offer is oversubscribed, the company will prorate the number of shares accepted for payment except for the odd lot. The repurchase program is valid till January 15, 2025. As of November 30, 2024, the company had 4,415,383 shares issued and outstanding. Duyuru • Dec 04
ATI Physical Therapy Receives Delisting Notice From NYSE ATI Physical Therapy, Inc. announced that it received notification from the New York Stock Exchange ("NYSE") indicating that the Company's Class A common stock will be delisted, and trading of its Class A common stock on the NYSE was suspended, after market close on December 3, 2024. The Company also announced that it is currently in discussions to obtain interim financing in an effort to provide a near-term opportunity for the Company's common stockholders to obtain liquidity. The Company anticipates that its Class A common stock will now begin trading publicly on the OTC Pink® Market. This transition to the over-the-counter market is not expected to affect the Company's business operations, its relationships with partners or employees, or its current Securities and Exchange Commission reporting obligations. "Over the past year, we have made meaningful progress strengthening our operating performance and positioning the company for growth," said Sharon Vitti, Chief Executive Officer of ATI. "We remain confident in our strategic plan as we continue to invest in our people and deliver exceptional experiences for patients." Joe Jordan, Chief Financial Officer of ATI, said, "The interim financing discussions we announced today are aligned to delivering liquidity to our stockholders while providing a possible path to a simpler capital structure." The NYSE reached its decision to delist the Company's Class A common stock pursuant to Rule 802.01B of the NYSE Listed Company Manual, which requires listed companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. Major Estimate Revision • Nov 17
Consensus EPS estimates fall by 14% The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -US$15.32 to -US$17.51 per share. Revenue forecast unchanged at US$745.4m. Healthcare industry in the US expected to see average net income growth of 28% next year. Consensus price target of US$3.00 unchanged from last update. Share price fell 22% to US$2.03 over the past week. New Risk • Nov 14
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.61m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (US$9.61m market cap). Minor Risks Less than 1 year of cash runway based on current free cash flow (-US$38m). Currently unprofitable and not forecast to become profitable next year (US$50m net loss next year). Share price has been volatile over the past 3 months (13% average weekly change). Price Target Changed • Nov 12
Price target decreased by 43% to US$3.00 Down from US$5.30, the current price target is provided by 1 analyst. New target price is 22% above last closing price of US$2.45. Stock is down 67% over the past year. The company is forecast to post a net loss per share of US$15.32 next year compared to a net loss per share of US$31.93 last year. New Risk • Nov 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-US$38m). Currently unprofitable and not forecast to become profitable next year (US$39m net loss next year). Share price has been volatile over the past 3 months (5.7% average weekly change). Shareholders have been diluted in the past year (4.6% increase in shares outstanding). Market cap is less than US$100m (US$22.7m market cap). Reported Earnings • Nov 05
Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2024 results: US$7.76 loss per share (further deteriorated from US$4.42 loss in 3Q 2023). Revenue: US$185.1m (up 6.3% from 3Q 2023). Net loss: US$33.8m (loss widened 84% from 3Q 2023). Revenue exceeded analyst estimates by 2.6%. Earnings per share (EPS) missed analyst estimates significantly. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 6.7% growth forecast for the Healthcare industry in the US. Duyuru • Oct 21
ATI Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 04, 2024 ATI Physical Therapy, Inc. announced that they will report Q3, 2024 results at 4:00 PM, US Eastern Standard Time on Nov 04, 2024 Major Estimate Revision • Aug 28
Consensus EPS estimates fall by 14% The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -US$9.70 to -US$11.06 per share. Revenue forecast unchanged at US$748.4m. Healthcare industry in the US expected to see average net income growth of 29% next year. Consensus price target of US$5.50 unchanged from last update. Share price rose 2.6% to US$6.06 over the past week. Major Estimate Revision • Aug 12
Consensus EPS estimates upgraded to US$9.70 loss The consensus outlook for fiscal year 2024 has been updated. 2024 losses forecast to reduce from -US$12.37 to -US$9.70 per share. Revenue forecast steady at US$748.7m. Healthcare industry in the US expected to see average net income growth of 29% next year. Consensus price target up from US$5.30 to US$5.50. Share price fell 2.2% to US$6.30 over the past week. Reported Earnings • Aug 06
Second quarter 2024 earnings: EPS exceeds analyst expectations Second quarter 2024 results: US$2.43 loss per share (improved from US$17.74 loss in 2Q 2023). Revenue: US$185.7m (up 9.2% from 2Q 2023). Net loss: US$10.6m (loss narrowed 86% from 2Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 67%. Revenue is forecast to grow 3.7% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Healthcare industry in the US. Duyuru • Aug 06
ATI Physical Therapy, Inc. Provides Revenue Guidance for the Third Quarter of 2024 ATI Physical Therapy, Inc. provided revenue guidance for the third quarter of 2024. For the period, the company expects net revenue to be in the range of $180 million to $190 million, which represents approximately 1% to 7% year-over-year growth. The Company anticipates it will continue growing patient visits through 2024 as it executes on its commercial, people, and operations strategies. Duyuru • Jul 27
ATI Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 05, 2024 ATI Physical Therapy, Inc. announced that they will report Q2, 2024 results After-Market on Aug 05, 2024 Price Target Changed • May 20
Price target decreased by 24% to US$5.30 Down from US$7.00, the current price target is provided by 1 analyst. New target price is 8.2% above last closing price of US$4.90. Stock is down 51% over the past year. The company is forecast to post a net loss per share of US$12.37 next year compared to a net loss per share of US$31.93 last year. Board Change • May 20
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Director Jeff Goldberg was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Duyuru • May 16
ATI Physical Therapy, Inc. Announces Executive Changes On May 13, 2024, ATI Physical Therapy, Inc. appointed Christopher Thunander to the position of Chief Accounting Officer. In this role, Mr. Thunander will serve as the Company’s Principal Accounting Officer. Previously, Joseph Jordan, the Company’s Chief Financial Officer, served as the Company’s Principal Accounting Officer on an interim basis. Mr. Thunander previously served as Director of Accounting beginning November 2020, and Vice President, Chief Accounting Officer and Corporate Controller beginning September 2021, of Surgalign Holdings, Inc. (“Surgalign”). In his roles with Surgalign, he was responsible for public company accounting activities, internal controls, external and Securities and Exchange Commission reporting functions, treasury and external audit coordination. Before joining Surgalign, Mr. Thunander spent 13 years at Ernst & Young, an audit firm, where he served in various roles in the Assurance and Audit practice. Mr. Thunander is a certified public accountant. He received his Masters of Business Administration and Bachelors of Science in Accounting and Finance from the University of Dayton. Duyuru • Apr 28
ATI Physical Therapy, Inc., Annual General Meeting, Jun 12, 2024 ATI Physical Therapy, Inc., Annual General Meeting, Jun 12, 2024, at 13:00 Central Standard Time. Agenda: To ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024; to elect nine Directors, each for a one-year term; to approve, on a non-binding advisory basis, the compensation of Named Executive Officers; to approve an amendment to the ATI Physical Therapy, Inc. 2021 Equity Incentive Plan to increase the number of shares available for issuance thereunder; and to transact other mtters. Duyuru • Apr 23
ATI Physical Therapy, Inc. to Report Q1, 2024 Results on May 06, 2024 ATI Physical Therapy, Inc. announced that they will report Q1, 2024 results After-Market on May 06, 2024 Duyuru • Feb 22
ATI Physical Therapy Announces Relocation of its Kirkland, Wash. Clinic to New Facility on 97th Lane in Kirkland ATI Physical Therapy announced the relocation of its Kirkland, Wash. clinic to a new facility on 97th Lane in Kirkland. This move signifies ATI's commitment to delivering exceptional physical therapy services while catering to the needs of the Greater Kirkland and neighboring areas. In collaboration with The Greater Kirkland Chamber of Commerce, ATI Physical Therapy will mark the occasion with a grand reopening event and ribbon-cutting ceremony at ATI Kirkland – 97th Lane on February 22, 2024, from 11:30 a.m. to 1 p.m., featuring the ribbon-cutting at 12 p.m. The clinic is located at 11620 97th Lane NE, Kirkland, Wash. 98034. Duyuru • Feb 13
ATI Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 26, 2024 ATI Physical Therapy, Inc. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2024 Duyuru • Dec 21
ATI Physical Therapy, Inc. Elects Jeff Goldberg to Serve on the Board of Directors On December 15, 2023, ATI Physical Therapy, Inc. elected Jeff Goldberg to serve on the Company’s Board of Directors, effective December 18, 2023. Mr. Goldberg was elected pursuant to designation rights of the holders of the Company’s Series A Preferred Stock included in the First Amended and Restated Certificate of Designation of Series A Senior Preferred Stock of the Company and the Investor's Rights Agreement, by and among the Company and the Preferred Equityholders party thereto, dated February 24, 2022, as amended by that certain First Amendment to Investor's Rights Agreement dated June 15, 2023. There are no other arrangements or understandings between Mr. Goldberg and any other persons pursuant to which he was elected as a director. There are no transactions and no proposed transactions between Mr. Goldberg and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K. Reported Earnings • Nov 09
Third quarter 2023 earnings: EPS and revenues exceed analyst expectations Third quarter 2023 results: US$3.66 loss per share (improved from US$29.76 loss in 3Q 2022). Revenue: US$174.1m (up 13% from 3Q 2022). Net loss: US$15.2m (loss narrowed 88% from 3Q 2022). Revenue exceeded analyst estimates by 4.8%. Earnings per share (EPS) also surpassed analyst estimates by 2.9%. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Healthcare industry in the US. Breakeven Date Change • Nov 07
No longer forecast to breakeven The 2 analysts covering ATI Physical Therapy no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$14.3m in 2025. New consensus forecast suggests the company will make a loss of US$52.5m in 2025. Duyuru • Oct 24
ATI Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 06, 2023 ATI Physical Therapy, Inc. announced that they will report Q3, 2023 results During-Market on Nov 06, 2023 Major Estimate Revision • Aug 15
Consensus EPS estimates fall by 56% The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -US$18.78 to -US$29.23 per share. Revenue forecast unchanged at US$676.7m. Healthcare industry in the US expected to see average net income growth of 17% next year. Consensus price target of US$14.50 unchanged from last update. Share price rose 10% to US$8.41 over the past week. Duyuru • Aug 09
ATI Physical Therapy, Inc. Provides Revenue Guidance for the Full Year 2023 ATI Physical Therapy, Inc. provided revenue guidance for the full year 2023. For the year, the company expected net revenue to be in the range of $680 million to $695 million, which represents approximately 7% to 9% year-over-year growth. New Risk • Aug 09
New minor risk - Financial position The company has less than a year of cash runway based on its current free cash flow. Free cash flow: -US$58m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-US$58m). Currently unprofitable and not forecast to become profitable next year (US$68m net loss next year). Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (US$31.9m market cap). Reported Earnings • Aug 08
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2023 results: US$17.74 loss per share (improved from US$34.49 loss in 2Q 2022). Revenue: US$170.0m (up 6.4% from 2Q 2022). Net loss: US$73.1m (loss narrowed 48% from 2Q 2022). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 55%. Revenue is forecast to grow 5.5% p.a. on average during the next 2 years, compared to a 7.0% growth forecast for the Healthcare industry in the US. Duyuru • Jul 25
ATI Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 07, 2023 ATI Physical Therapy, Inc. announced that they will report Q2, 2023 results After-Market on Aug 07, 2023 Duyuru • Jul 04
ATI Physical Therapy Receives NYSE Non-Compliance Letter Regarding Market Capitalization Requirements ATI Physical Therapy, Inc. announced that on June 28, 2023, the Company received a written notice (the "Notice") from the New York Stock Exchange (the "NYSE") that the Company no longer satisfies the continued listing standards set forth under Section 802.01B of the NYSE's Listed Company Manual. The notice cited that the Company's average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company's last reported stockholders' equity was less than $50 million. As of June 27, 2023, the 30 trading-day average market capitalization was approximately $41 million, and its last reported stockholders' equity was approximately $20.5 million as of March 31, 2023. According to NYSE procedures, the Company has 45 days from the date the Notice was received to submit a business plan advising the NYSE of the definitive action(s) the Company has taken, or is taking, to bring it into compliance within 18 months of receipt of the Notice. Within 45 days of its receipt, the NYSE will review the plan and determine whether the Company has made a reasonable demonstration to conform to the compliance requirements within the 18-month period. Pending NYSE acceptance of the plan, the Company's common stock will continue to be listed and traded on the NYSE during the 18-month period. Continued listing is also subject to the Company's compliance with other applicable NYSE requirements and to periodic NYSE review of the Company's progress toward achieving the previously submitted plan. In the interim, the Company's common stock will continue to trade on the NYSE under the symbol "ATIP" with the designation of ".BC" to indicate the status of the shares as "below criteria," but is otherwise not immediately impacted by the Notice. The Notice also does not affect Securities and Exchange Commission reporting obligations by the Company, nor does it conflict with or prompt default under any of the Company's material debt or other agreements. In addition, in its June 28, 2023 written notice, the NYSE advised the Company that it remains subject to the conditions set forth in the NYSE's November 18, 2022 letter regarding noncompliance with the $1.00 over a 30 trading-day average price standard. The Company believes that it is in the process of regaining such compliance as a result of its previously announced reverse stock split effective June 15, 2023. Duyuru • Jun 16
ATI Physical Therapy, Inc. announced that it has received $25 million in funding from ATI Holdings Acquisition, Inc., Wilmington Savings Fund Society, FSB, Wilco Intermediate Holdings, Inc. On June 15, 2023, ATI Physical Therapy, Inc. closed the transaction. Duyuru • Jun 15
ATI Physical Therapy Announces Reverse Stock Split to Regain Compliance ATI Physical Therapy, Inc. announced that its Board of Directors has approved a one-for-fifty (1-for-50) reverse stock split (the "Reverse Stock Split") of ATI's Class A common stock, par value $0.0001 per share (the "Class A Common Stock"). The Reverse Stock Split was approved by ATI's stockholders at a Meeting of Stockholders held virtually on June 13, 2023. The Reverse Stock Split will become effective at 4:01 p.m. Eastern Time on June 14, 2023, and the Class A Common Stock will open for trading on The New York Stock Exchange (the "NYSE") on a reverse split-adjusted basis on June 15, 2023 under the existing trading symbol "ATIP." The Reverse Stock Split is intended to increase the market price per share of the Company's Class A Common Stock to regain compliance with the minimum bid continued listing requirement of the NYSE. Price Target Changed • Jun 06
Price target decreased by 41% to US$0.29 Down from US$0.49, the current price target is provided by 1 analyst. New target price is 84% above last closing price of US$0.16. Stock is down 93% over the past year. The company is forecast to post a net loss per share of US$0.38 next year compared to a net loss per share of US$2.51 last year. Reported Earnings • May 10
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2023 results: US$0.13 loss per share (improved from US$0.70 loss in 1Q 2022). Revenue: US$162.8m (up 9.5% from 1Q 2022). Net loss: US$26.3m (loss narrowed 81% from 1Q 2022). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 58%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Healthcare industry in the US. Reported Earnings • Mar 17
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: US$2.51 loss per share (improved from US$4.69 loss in FY 2021). Revenue: US$621.8m (up 1.7% from FY 2021). Net loss: US$510.3m (loss narrowed 34% from FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 73%. Revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Healthcare industry in the US. Duyuru • Dec 23
ATI Physical Therapy, Inc. Names Scott Gregerson as Chief Growth Officer Beginning Jan. 3, 2023 ATI Physical Therapy, Inc. announced that Scott Gregerson will join ATI as its new Chief Growth Officer beginning Jan. 3, 2023. Gregerson brings two decades of experience as a healthcare executive to ATI, including several roles leading business development and strategic partnerships for large care systems. As CGO, Gregerson will lead growth initiatives across business development, mergers and acquisitions, sales, marketing, real estate, and other potential future growth opportunities. Over the last decade, Gregerson has held executive leadership positions at Envison Healthcare, Epic Care, Stanford Healthcare and ValleyCare Health. In these chief-executive, presidential and vice-presidential roles he developed and led strategic business development and growth, often connecting large-scale provider groups with hospital and health systems. His prior experience also includes healthcare leadership positions at Fresenius Medical Care (Chicago), Doctors Community Hospital (Lanham, MD) and Sonoma Valley Hospital (Sonoma, Calif). Gregerson holds a bachelor's degree from the University of California, Santa Barbara and a juris doctor degree from Washington and Lee University School of Law. Duyuru • Dec 15
ATI Physical Therapy, Inc. Announces Christopher Cox as Chief Operating Officer, Effective December 16, 2022 ATI Physical Therapy, Inc. announced that healthcare operations veteran Christopher Cox will join ATI as its new Chief Operating Officer beginning Dec. 16. Cox has more than 17 years' experience in the healthcare sector, including more than 10 years in operational leadership roles. Cox's arrival brings a new purview of the COO role at ATI, including oversight of the Company's ATI Worksite Solutions and Sports Medicine businesses — together known as Health Services — as well as field operations, revenue cycle management, payer contracting and reimbursement, central scheduling and telehealth support, and transformation & enterprise project management. Cox comes to ATI after nearly 15 years in progressively higher-level leadership positions at CVS Health, including five years in vice presidential roles over store operations, strategy and growth, and three years as Senior Vice President, Retail Pharmacy. In his last role at CVS, Cox was accountable for the $80Bn+ Retail Pharmacy P&L and also served to oversee the development, implementation, and operational oversight of the company's COVID-19 vaccine efforts. He most recently served a brief term as Executive Vice President, Enterprise Operations at Advantage Solutions before leaving to join ATI. He holds an M.B.A. from The Wharton School at the University of Pennsylvania with a dual concentration in Finance and General Management, and an undergraduate degree from Duke University. Duyuru • Nov 30
Ray Wahl Announces, Effective December 16, 2022, from the Position of Chief Operating Officer of ATI Physical Therapy, Inc On November 22, 2022, Ray Wahl gave notice of his intended resignation, effective December 16, 2022, from the position of Chief Operating Officer of ATI Physical Therapy, Inc. in order to pursue other opportunities. Major Estimate Revision • Nov 16
Consensus EPS estimates fall by 89% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from US$645.6m to US$636.6m. Losses expected to increase from US$1.12 per share to US$2.11. Healthcare industry in the US expected to see average net income growth of 6.4% next year. Consensus price target of US$1.34 unchanged from last update. Share price fell 14% to US$0.58 over the past week. Board Change • Nov 16
High number of new directors There are 6 new directors who have joined the board in the last 3 years. CEO & Director Sharon Vitti was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Price Target Changed • Nov 11
Price target decreased to US$1.34 Down from US$1.51, the current price target is an average from 4 analysts. New target price is 100% above last closing price of US$0.67. Stock is down 83% over the past year. The company is forecast to post a net loss per share of US$2.11 next year compared to a net loss per share of US$4.69 last year. Duyuru • Nov 09
ATI Physical Therapy, Inc. Announces That Erik Kantz Has Been Promoted to the Role of Chief Legal Officer and Corporate Secretary ATI Physical Therapy, Inc. announced that Erik Kantz has been promoted to the role of Chief Legal Officer and Corporate Secretary. Kantz has served as Vice President and Deputy General Counsel for the Company since 2019.Kantz came to ATI in 2016 as Assistant General Counsel Mergers & Acquisitions. Prior to that, Kantz was a partner and Vice Chair of the Business Group at Saul Ewing Arnstein & Lehr LLP, and was previously partner and Director of Operations at College Sports Chicago. He holds a bachelor's degree from Illinois Wesleyan University and a juris doctor degree from DePaul University. Reported Earnings • Nov 08
Third quarter 2022 earnings released: US$0.59 loss per share (vs US$1.68 loss in 3Q 2021) Third quarter 2022 results: US$0.59 loss per share (improved from US$1.68 loss in 3Q 2021). Revenue: US$154.0m (down 1.0% from 3Q 2021). Net loss: US$116.7m (loss narrowed 65% from 3Q 2021). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Healthcare industry in the US. Duyuru • Oct 25
ATI Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 07, 2022 ATI Physical Therapy, Inc. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2022 Duyuru • Sep 25
ATI Physical Therapy, Inc. Announces Resignation of Diana Chafey as Chief Legal Officer and Corporate Secretary, Effective on or About November 4, 2022 ATI Physical Therapy, Inc. announced that on September 20, 2022, Diana Chafey gave notice of her intended resignation, effective on or about November 4, 2022, from the position of Chief Legal Officer and Corporate Secretary of the company including its affiliates and subsidiaries (the Company), in order to pursue other opportunities. Major Estimate Revision • Aug 16
Consensus EPS estimates fall by 76% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from US$687.7m to US$646.2m. Losses expected to increase from US$0.70 per share to US$1.23. Healthcare industry in the US expected to see average net income growth of 0.6% next year. Consensus price target down from US$2.96 to US$1.68. Share price fell 19% to US$0.95 over the past week. Duyuru • Aug 10
ATI Physical Therapy, Inc. Appoints Eimile Tansey as Chief People Officer ATI Physical Therapy announced that Eimile Tansey will be joining the company later this month as Chief People Officer. Tansey will lead ATI's priority initiatives to drive excellence in employee recruiting, hiring, training and retention as critical elements of the Company's growth strategy. In a field in which more than 60% of clinicians are women, Tansey joins Vitti and Chief Legal Officer Diana Chafey as the third woman on the Company's executive leadership team. Among her early priorities, Tansey emphasized the importance of promoting a culture of inclusivity. Tansey has more than 20 years' experience in Human Resources and Operations across a variety of industries such as healthcare, manufacturing and more, including more than 15 years in leadership and executive roles. She comes to ATI after having most recently served as Chief People Officer at elder-care provider InnovAge. Prior to that, Tansey held various HR leadership positions at CVS Health for more than a decade, rising to Vice President of Human Resources. She holds a Master of Science, Human Resources Management/Personnel Administration from the University of Maryland Global Campus and a Bachelor of Arts in Political Science and Government from Ohio Wesleyan University. Duyuru • Aug 09
ATI Physical Therapy, Inc. Revises Guidance for Full Year 2022 ATI Physical Therapy, Inc. revised guidance for full year 2022. For the year, the company revised guidance for net operating revenue to be in a range of $635 million to $655 million. Price Target Changed • Aug 09
Price target decreased to US$2.48 Down from US$3.05, the current price target is an average from 6 analysts. New target price is 136% above last closing price of US$1.05. Stock is down 74% over the past year. The company is forecast to post a net loss per share of US$0.70 next year compared to a net loss per share of US$4.69 last year. Reported Earnings • Aug 09
Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2022 results: US$0.69 loss per share (up from US$2.21 loss in 2Q 2021). Revenue: US$159.8m (flat on 2Q 2021). Net loss: US$135.7m (loss narrowed 69% from 2Q 2021). Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) exceeded analyst estimates by 100%. Over the next year, revenue is forecast to grow 18%, compared to a 8.1% growth forecast for the industry in the US. Duyuru • Jul 26
ATI Physical Therapy, Inc. to Report Q2, 2022 Results on Aug 08, 2022 ATI Physical Therapy, Inc. announced that they will report Q2, 2022 results After-Market on Aug 08, 2022 Major Estimate Revision • May 17
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 expected loss increased from -US$0.31 to -US$0.70 per share. Revenue forecast unchanged at US$687.7m. Healthcare industry in the US expected to see average net income growth of 6.3% next year. Consensus price target down from US$3.05 to US$2.96. Share price rose 20% to US$1.68 over the past week. Reported Earnings • May 10
First quarter 2022 earnings: EPS exceeds analyst expectations First quarter 2022 results: US$0.70 loss per share. Revenue: US$148.7m (up 4.8% from 1Q 2021). Net loss: US$138.2m (loss widened US$119.1m from 1Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 100%. Over the next year, revenue is forecast to grow 15%, compared to a 8.8% growth forecast for the industry in the US. Duyuru • May 10
ATI Physical Therapy, Inc. Reaffirms Earnings Guidance for the Year 2022 ATI Physical Therapy, Inc. reaffirmed earnings guidance for the year 2022. For the year, the company expects net operating revenue to be in a range of $675 million to $705 million. Board Change • Apr 27
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Dan Dourney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Duyuru • Apr 22
ATI Physical Therapy, Inc., Annual General Meeting, Jun 02, 2022 ATI Physical Therapy, Inc., Annual General Meeting, Jun 02, 2022, at 10:00 Central Standard Time. Agenda: 1. To discuss two Class I directors of ATI Physical Therapy, Inc., each to serve a three-year term expiring at the 2025 annual meeting of stockholders and until such director's successor is duly BUSINESS: Eected and qualified; Ratify the appointment of PricewaterhouseCoopers LLP ( PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2022; Approve, on a non-binding advisory basis, the compensation of our named executive officers; Select, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years; Approve an amendment to the ATI Physical Therapy 2021 Equity Incentive Plan to increase the number of shares available for issuance under the Plan in connection with the cancellation of certain shares previously held by Wilco Acquisition, LP and the forfeiture of certain shares subject to Restricted Stock Agreements. Duyuru • Apr 19
ATI Physical Therapy, Inc. to Report Q1, 2022 Results on May 09, 2022 ATI Physical Therapy, Inc. announced that they will report Q1, 2022 results After-Market on May 09, 2022 Board Change • Apr 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Dan Dourney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Mar 04
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 expected loss increased from -US$0.17 to -US$0.41 per share. Revenue forecast unchanged at US$701.1m. Healthcare industry in the US expected to see average net income growth of 2.9% next year. Consensus price target down from US$4.83 to US$4.08. Share price fell 30% to US$1.75 over the past week. Price Target Changed • Mar 03
Price target decreased to US$4.08 Down from US$4.83, the current price target is an average from 4 analysts. New target price is 129% above last closing price of US$1.78. Stock is down 82% over the past year. The company is forecast to post a net loss per share of US$0.41 next year compared to a net loss per share of US$3.96 last year. Board Change • Mar 01
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Jamie Parisi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Duyuru • Feb 27
ATI Physical Therapy, Inc. Announces Executive Changes On February 18, 2022, Christopher Krubert resigned from the Board of Directors of ATI Physical Therapy, Inc. and each committee of which he was a member, effective February 24, 2022. Mr. Larsen has joined the Compensation Committee to replace Mr. Krubert. On February 24, 2022, pursuant to the Certificate of Designation and Investors’ Rights Agreement, the holders of shares of Series A Preferred Stock elected Daniel V. Dourney to serve on the Company’s Board effective February 24, 2022. From April 2019 to June 2021, Mr. Dourney served as President and Chief Executive Officer of Professional PT, LLC. Previously, from May 2016 to March 2019, he was the President and Chief Operations Officer of OptimisCorp. Reported Earnings • Feb 26
Full year 2021 earnings: EPS misses analyst expectations Full year 2021 results: US$3.96 loss per share (down from US$0.13 loss in FY 2020). Revenue: US$611.5m (up 6.2% from FY 2020). Net loss: US$782.0m (loss widened US$776.7m from FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 13%, compared to a 9.8% growth forecast for the industry in the US. Duyuru • Feb 26
ATI Physical Therapy, Inc. Provides Earnings Guidance for the Year 2022 ATI Physical Therapy, Inc. provided earnings guidance for the year 2022. For the year, the company expects net operating revenue to be in a range of $675 million to $705 million, which represents approximately 7.5% to 12.3% year over year growth. Duyuru • Feb 12
ATI Physical Therapy, Inc. to Report Q4, 2021 Results on Feb 25, 2022 ATI Physical Therapy, Inc. announced that they will report Q4, 2021 results Pre-Market on Feb 25, 2022 Major Estimate Revision • Dec 17
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 losses forecast to reduce from -US$4.74 to -US$4.07 per share. Revenue forecast unchanged from US$627.7m at last update. Healthcare industry in the US expected to see average net income growth of 12% next year. Consensus price target of US$4.83 unchanged from last update. Share price fell 15% to US$3.14 over the past week. Duyuru • Dec 11
ATI Physical Therapy, Inc. (NYSE:ATIP) acquired Auburn Physical Therapy. ATI Physical Therapy, Inc. (NYSE:ATIP) acquired Auburn Physical Therapy on December 9, 2021.
ATI Physical Therapy, Inc. (NYSE:ATIP) completed the acquisition of Auburn Physical Therapy on December 9, 2021. 
